Guidelines and Reality in Practical Use of and compliance to Antidepressants in the Treatment of Depression: Incidence Survey in Lorraine and Champagne-Ardenne (France);Réalités et recommandations dans la prescription et l'observance des antidépresseurs en médecine générale : évaluation des pratiques dans le traitement de la dépression en Lorraine et Champagne-Ardenne

Encephale

Volumn 35, Issue 1, 2009, Pages 73-79

  Herique A ^a   Kahn, J P ^b  

^a Echelon Régional du Service Médical CNAMTS   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Compliance; Depression; Evaluation and improvement of professional practices; Pharmacotherapy

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; DOXEPIN; FLUOXETINE; IMIPRAMINE; MAPROTILINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FRANCE; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; QUESTIONNAIRE; RETROSPECTIVE STUDY; STANDARDIZATION;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FAMILY PRACTICE; FEMALE; FRANCE; GUIDELINE ADHERENCE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRESCRIPTIONS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 61349129198     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2007.12.010     Document Type: Article

References (31)

1. Agence française de sécurité sanitaire des produits de santé. Bon usage des médicaments antidépresseurs dans le traitement des troubles dépressifs et des troubles anxieux de l'adulte. Recommandations. Oct 2006. Available from: URL : http://agmed.sante.gouv.fr/pdf/5/rbp/reco_antide_presseur_adultes.pdf
2. Agence nationale d'accréditation et d'évaluation en santé. Prise en charge d'un épisode dépressif isolé de l'adulte en ambulatoire. Paris: ANAES; 2002.
3. Agency for Health Care Policy and Research. Depression in primary care. Volume 2. Treatment of Major Depression. Clinical Practice Guidelines. Rockville : AHCPR; 1993.
4. American Psychiatric, and Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 157 (2000) 1-45
5. Auriat N. Les défaillances de la mémoire humaine : aspects cognitifs des enquêtes rétrospectives (1996), Presses Universitaires de France - INED, Paris
6. Centre for Health Services Research. The choice of antidepressants for depression in primary care. Evidence-based clinical practice guideline. (1998), CHSR, Newcastle
7. Direction de la recherche, des études, de l'évaluation et des statistiques. Les ventes d'antidépresseurs entre 1980 et 2001, Études et résultat; 2004. Paris; Dress N° 285.
8. Griffiths K.M., Christensen H., Jorm A.F., et al. Effect of web-based depression literacy and cognitive-behavioural therapy interventions on stigmatising attitudes to depression: randomised controlled trial. Br J Psychiatry 185 (2004) 342-349
9. Johnson J., Weissman M.M., and Klerman G.L. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 267 11 (1992) 1478-1483
10. Kasper S., Schindler S., and Neumeister A. Risk of suicide in depression and its implication for psychopharmacological treatment. Int Clin Psychopharmacol 11 2 (1996) 71-79
11. Lecadet J., Vidal P., Baris B., et al., le groupe Médipath. Médicaments psychotropes : consommation et pratiques de prescription en France métropolitaine. I. Données nationales, 2000. Rev Med Ass Maladie 34 (2003) 75-84
12. Le Fur P., Le Pape A., and Sermet C. La prescription pharmaceutique des médecins libéraux (1998), CREDES, Paris
13. Le Pape A., and Lecomte T. Prévalence et prise en charge médicale de la depression, France 1996-1997 (1999), CREDES, Paris
14. Lépine J.P., Gasquet V., Kovess S., et al. Prévalence et comorbidité des troubles psychiatriques dans la population générale française : résultats de l'étude épidémiologique ESEMeD/MHEDEA 2000/(ESEMeD). Encéphale 31 2 (2005) 182-194
15. Lepine J.P., Gastpar M., Mendlewicz J., et al. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 12 1 (1997) 19-29
16. Martin P. L'association antidépresseur et anxiolytique aujourd'hui : bilan et prospective. Encéphale 32 (2006) 753-766
17. National Health Committee on Health and Disability. Guidelines for the treatment and management of depression by primary healthcare professionals (1996), NHC, Auckland
18. Nutting P.A., Dickinson L.M., Rubenstein L.V., et al. Improving detection of suicidal ideation among depressed patients in primary care. Ann Fam Med 3 6 (2005) 529-536
19. Olie J.P., El Omari F., Spadone C., et al. Résultats d'une enquête sur l'usage des antidépresseurs en population générale française. Encéphale 28 (2002) 411-417
20. Ormel J., VonKorff M., Ustun T.B., et al. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 272 22 (1994) 1741-1748 14
21. Rost K., Smith J.L., and Dickinson M. The effect of improving primary care depression management on employee absenteeism and productivity. Med Care 42 12 (2004) 1202-1210
22. Rutz W., von Knorring L., and Walinder J. Long-term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiatr Scand. 85 1 (1992) 83-88
23. Rutz W., von Knorring L., Walinder J., et al. Effect of an educational program for general practitioners on Gotland on the pattern of prescription of psychotropic drugs. Acta Psychiatr Scand 82 6 (1990) 399-403
24. Sleath B., Wurst K., and Lowery T. Drug information sources and antidepressant adherence. Community Ment Health J 39 4 (2003) 359-368
25. Stewart W.F., Ricci J.A., Chee E., et al. Cost of lost productive work time among US workers with depression. JAMA 289 23 (2003) 3135-3144
26. Taleb M., Rouillon F., Hegerl U., et al. Les Programmes d'action contre la dépression. Encéphale 32 (2006) 9-15
27. Thornicroft G., and Sartorius N. The course and outcome of depression in different cultures: 10-year follow-up of the WHO Collaborative Study on the Assessment of Depressive Disorders. Psychol Med 23 4 (1993) 1023-1032
28. URCAM Rhône-Alpes - Observatoire du médicament. Les inhibiteurs sélectifs de la recapture de la sérotonine chez l'adulte : les traitements courts. Available from : URL: http://www.rhone-alpes.assurance-maladie.fr/fileadmin/RHONE-ALPES/publications/Etudes_2003_ODM_Rapport_ISRS.pdf
29. Verger P., Brabis P.A., Kovess V., et al. Determinants of early identification of suicidal ideation in patients treated with antidepressants or anxiolytics in general practice: A multilevel analysis. J Affect Disord 99 (2007) 253-257
30. Weilburg J.B., O'Leary K.M., Meigs J.B., et al. Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv 54 9 (2003) 1233-1239
31. Wells K.B., Stewart A., Hays R.D., et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 262 7 (1989) 914-919